ERNA vs MET · P/E 0.0, rev $582.0K vs P/E 13, $52.16B cap
Eterna Therapeutics Inc (ERNA) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
MET does not have a complete income-statement cache yet.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the ERNA and MET stock pages for the full models.
Not investment advice.